These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 2523144)
41. Infectious tolerance mediated by CD8+ T-suppresor cells after UV-B-irradiated donor-specific transfusion and rat heart transplantation. Witkowski P; Liu JW; Jin MX; Liu Z; Suciu-Foca N; Hardy MA Transplant Proc; 2005; 37(1):43-5. PubMed ID: 15808541 [TBL] [Abstract][Full Text] [Related]
42. Synergistic interactions between anti-interleukin-2 receptor (IL-2R) MAb and CyA in sensitized rat recipients of cardiac allografts. Kupiec-Weglinski JW; Sablinski T; Hancock WW; Mix CT; Tilney NL Transplant Proc; 1991 Feb; 23(1 Pt 1):285-6. PubMed ID: 1990533 [No Abstract] [Full Text] [Related]
43. Tolerance induction to cardiac allografts by simultaneous or sequential intrathymic inoculation of disparate alloantigens. Shimomura K; Hardy MA; Oluwole SF Transplantation; 1995 Oct; 60(8):806-11. PubMed ID: 7482739 [TBL] [Abstract][Full Text] [Related]
44. Induction of antigen-specific tolerance: antigen form and injection route. Yoshimura N; Hamashima T; Oka T Transplant Proc; 1996 Jun; 28(3):1150-1. PubMed ID: 8658604 [No Abstract] [Full Text] [Related]
45. Prolongation of cardiac allograft survival following intraportal injection of donor antigen is inhibited by cyclosporine A. Farges O; Buffello D; Shi YM; Moufetier A; Bismuth H Transplant Proc; 1995 Aug; 27(4):2525-7. PubMed ID: 7652915 [No Abstract] [Full Text] [Related]
46. Effects of a combined antigen-cyclosporine regimen in four transplantation models. Didlake R; Kakazaki K; Yoshimura N; Merrell R; Kahan BD Transplant Proc; 1987 Feb; 19(1 Pt 2):1281-3. PubMed ID: 3152626 [No Abstract] [Full Text] [Related]
47. Suppressor cells influence maintenance and reversal of late rejection in indefinitely surviving skin allografts in cyclosporine-treated rats. Thornburg LE; Padberg WM; Towpik E; Tilney NL Transplant Proc; 1988 Jun; 20(3 Suppl 3):1025-30. PubMed ID: 2968692 [No Abstract] [Full Text] [Related]
49. Donor-specific transfusion and cyclosporine prolong allograft survival when given in the peroperative period. Cofer BR; Tchervenkov JI; Alexander JW; Barnwell SC Transplant Proc; 1991 Feb; 23(1 Pt 1):157-8. PubMed ID: 1990501 [No Abstract] [Full Text] [Related]
50. Sponge allograft effector cells exert suppressor function via an L-arginine-dependent mechanism. Langrehr JM; Hoffman RA; Lee KW; Billiar TR; Schraut WH; Simmons RL Transplant Proc; 1991 Feb; 23(1 Pt 1):839-40. PubMed ID: 1825002 [No Abstract] [Full Text] [Related]
51. Induction of long-term rat renal allograft survival: a specific synergistic effect of limited pretransplant cyclosporine combined with multiple nonspecific blood transfusions. Martin DC; Hewitt CW; Black KS; Reyes M; Go C Transplant Proc; 1987 Feb; 19(1 Pt 1):462-3. PubMed ID: 3274807 [No Abstract] [Full Text] [Related]
52. Effect of combined administration of low dose cyclosporine A with a thromboxane synthetase inhibitor on acute cardiac allograft rejection. Sakurai Y; Kagawa K; Kato Y; Otani H; Nonoyama A Transplant Proc; 1990 Aug; 22(4):1686-8. PubMed ID: 2389433 [No Abstract] [Full Text] [Related]
53. Cyclosporine-induced transplantation unresponsiveness in rat cardiac allograft recipients: in vitro determination of helper and suppressor activity. Uhteg LC; Salomon DR; Rocher LL; Kupiec-Weglinski JW; Araujo JL; Rubin MF; Tilney NL; Carpenter CB J Immunol; 1985 Sep; 135(3):1800-5. PubMed ID: 3160780 [TBL] [Abstract][Full Text] [Related]
54. Effects of anti-IL 2 receptor monoclonal antibody and cyclosporine on IL 2 receptor-positive cells infiltrating cardiac allografts in the rat. Lord RH; Hancock WW; Colby AJ; Padberg W; Diamantstein T; Kupiec-Weglinski JW; Tilney NL Transplant Proc; 1987 Feb; 19(1 Pt 1):354-5. PubMed ID: 3079156 [No Abstract] [Full Text] [Related]
55. Prolongation of organ allograft survival by syngeneic lymphoid cells. Tilney NL; Graves MJ; Strom TB J Immunol; 1978 Oct; 121(4):1480-2. PubMed ID: 359709 [No Abstract] [Full Text] [Related]
56. Prolongation of rat heart allograft survival using low-dose cyclosporine and PAF antagonist WEB 2170. Da Costa M; Metcalfe S; Calne RY Transplant Proc; 1990 Aug; 22(4):1945-6. PubMed ID: 2389490 [No Abstract] [Full Text] [Related]
57. Total lymphoid irradiation and cyclosporine prolongs cardiac allograft survival in the sensitized rat model. Harland RC; Halperin EC; Yamaguchi Y; Ruiz P; Scroggs MW; Sanfilippo F; Bollinger RR Transplant Proc; 1989 Feb; 21(1 Pt 1):1118-9. PubMed ID: 2650071 [No Abstract] [Full Text] [Related]
58. Donor-soluble histocompatibility antigen selectively potentiates suppressor elements while decreasing the frequency of alloantigen-specific T cytotoxic cells. Stepkowski SM; Ghobrial R; Wang B; Ito Y; Goto S; Hamashima T; Kahan BD Transplant Proc; 1993 Oct; 25(5):2875. PubMed ID: 8212270 [No Abstract] [Full Text] [Related]
59. Donor-specific renal, but not cardiac, allograft tolerance promotes engraftment of the normally rejected rat skin graft. Margenthaler JA; Yu S; Otomo N; Lehmann M; Flye MW Transpl Int; 2003 Oct; 16(10):713-20. PubMed ID: 12827227 [TBL] [Abstract][Full Text] [Related]